{
  "docId": "019dd923-622c-750b-8b99-9ee2a1e788fb",
  "docSlug": "1233d0b05ad9",
  "documentTitle": "PROCEPT BioRobotics Corporation (PRCT)",
  "authorId": "54_Spruce_Point_Capital",
  "authorName": "Spruce Point Capital Management",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2025-01-16 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 16,
  "pageCount": 100,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "problem_statement",
  "function": "frame_problem",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide establishes the medical context for the activist thesis, specifically positioning Procept's product as a 'resective' procedure for serious cases.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "process_diagram",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b99-9ee2a1e788fb/16",
  "deckHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b99-9ee2a1e788fb#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.04,
        "w": 0.98,
        "x": 0.01,
        "y": 0.89
      },
      "kind": "callout",
      "text": "Procept's Aquablation is a resective surgical procedure, meaning it is generally used only when LUTS become serious.",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b740807a-c6d7-442a-af4e-82f2450cb12d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "callout",
      "text": "Procept’s Aquablation is a resective surgical procedure, meaning it is generally used only when LUTS become serious.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-ee35-7258-b4d7-f9c93ecce97d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.98,
        "x": 0.01,
        "y": 0.77
      },
      "kind": "diagram",
      "text": "The AUA BPH Treatment Progression After Active Surveillance (Once LUTS Demand Intervention) Drugs -> MISTS -> Resective Surgery",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a1bfa66-02b1-4aa4-b554-c84ea321bffc",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.48,
        "w": 0.96,
        "x": 0.02,
        "y": 0.23
      },
      "kind": "list",
      "text": "What is it? Benign prostatic hyperplasia (BPH) refers to the expansion of the prostate... Who gets it? Approximately half of men aged 60-79... How is it treated? The established standard of care... What factors impact the treatment approach?",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "203220f2-802a-4584-a85b-a493a87c1aa2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.98,
        "x": 0.01,
        "y": 0.17
      },
      "kind": "paragraph",
      "text": "The Basics on BPH and the Current Approach to Treatment",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "884c2809-ddad-47ac-ac97-7200b31f8d08",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.98,
        "x": 0.01,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "Source: AUA Treatment Guidelines for BPH, Urology Care Foundation BPH overview, \"National Trends in Surgical Management for Benign Prostatic Hyperplasia From 2013 to 2019 in the United States\", Feiertag and Clark, Spruce Point research",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "03a61b31-1f72-48e4-8745-da00eb6f5324",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.65,
        "x": 0.31,
        "y": 0.04
      },
      "kind": "title",
      "text": "What Is Benign Prostatic Hyperplasia (BPH)?",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "24a11289-7ab7-41a6-8a4d-7f0ae954f39d",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "045d7d32-a07f-4cfb-b8a0-6d87f8b41ae7",
      "evidence": "Treatment progression diagram",
      "confidence": 0.8
    }
  ],
  "arcBeats": [],
  "loops": [
    {
      "to": 20,
      "from": 11,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "7ffce90f-7469-4962-8ccc-f8b71e2baf08",
      "evidence": "Analysis of the BPH treatment market and the trade-offs of BPH treatments",
      "position": 0,
      "objective": "Highlighting the risks and limitations of Procept's Aquablation procedure",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}